MedPath

A clinical study to compare the efficacy of two blocks in breast surgery

Phase 3
Completed
Conditions
Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Registration Number
CTRI/2019/11/022118
Lead Sponsor
AIIMS RAIPUR
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
66
Inclusion Criteria

1.American Society of Anesthesiologists Grade I and II

2.Scheduled for unilateral Modified Radical Mastectomy

Exclusion Criteria

1.Patients not willing to give consent

2.Patients with psychiatric disorder

3.Patients having pre-existing neurological disease

4.Patients having BMI > 30 Kg/m2

5.Infection at the injection site

6.Patients with coagulopathy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Duration of analgesia(time to first rescue analgesia after administration of block), total analgesic consumptionTimepoint: 0,1,2,4,8,12 and 24 hrs.
Secondary Outcome Measures
NameTimeMethod
Adverse effects 24 hrs. after surgeryTimepoint: 24 hrs.
© Copyright 2025. All Rights Reserved by MedPath